Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363
Ontology highlight
ABSTRACT: Targeting KAT6A/KAT6B dependencies in breast cancer with a novel selective, orally bioavailable KAT6 inhibitor, CTx-648/PF-9363
PROVIDER: PRJNA977979 | ENA |
REPOSITORIES: ENA
ACCESS DATA